Dragon-tiger fighting needling therapy in treatment of painful diabetic peripheral neuropathy: a randomized controlled trial.
10.13703/j.0255-2930.20200105-0004
- Author:
Xiu-Min DENG
1
;
Shi-Wei LIU
1
;
Jia LEI
1
;
Xin-Tong LI
1
;
Hong-Ye JIANG
1
Author Information
1. Department of Endocrinology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China.
- Publication Type:Randomized Controlled Trial
- Keywords:
acupuncture;
dragon-tiger fighter needling;
nerve conduction velocity;
painful diabetic peripheral neuropathy;
quality of life;
visual analogue scale (VAS)
- MeSH:
Acupuncture Points;
Acupuncture Therapy;
Animals;
Diabetes Mellitus;
Diabetic Neuropathies/drug therapy*;
Humans;
Quality of Life;
Tigers;
Treatment Outcome
- From:
Chinese Acupuncture & Moxibustion
2021;41(1):23-26
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To compare the clinical therapeutic effect on painful diabetic peripheral neuropathy (PDPN) between dragon-tiger fighting needling and pregabalin capsules.
METHODS:A total of 60 patients with PDPN were randomized into an observation group and a control group, 30 cases in each one. On the base of treatment with routine anti-hyperglycaemic measures and nutritional neurotherapy, the dragon-tiger fighting needling was exerted at Sanyinjiao (SP 6), Zusanli (ST 36), Yinlingquan (SP 9) and Xuehai (SP 10) in the observation group, once daily. Pregabalin capsules were prescribed for oral administration in the control group, 75 mg, twice a day. The treatment for 2 weeks was as one course and 2 courses of treatment were required in total. The score of visual analogue scale (VAS), the score of MOS item short form health survey (SF-36) and nerve conduction velocity before and after treatment were compared between the two groups. The clinical therapeutic effect was evaluated in the two groups.
RESULTS:After treatment, VAS score was reduced as compared with before treatment in the two groups (
CONCLUSION:The dragon-tiger fighting needling therapy relieves painful symptoms, improves the quality of life and increases nerve conduction velocity in the patients with diabetic peripheral neuropathy, and the therapeutic effect is better than oral administration of pregabalin capsules.
